Global Biologic Therapeutics Market 2014-2018


Naperville, IL -- (SBWIRE) -- 11/03/2014 -- Reportstack, provider of premium market research reports announces the addition of Global Biologic Therapeutics Market 2014-2018 market report to its offering.

About Biologic Therapeutics
Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogenicity. Biologic products are generally characterized by high molecular weight and complex structures. These products are usually derived from living entities and are less easily characterized compared to small molecules. These products are often susceptible to extreme temperatures and light.

Analysts forecast the Global Biologic Therapeutics market to grow at a CAGR of 8.22 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Biologic Therapeutics market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of the following drugs:

Protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics)

Vaccines (pediatric vaccines and adult vaccines)

Cell therapy

The Other Protein Therapeutics segment covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.

Global Biologic Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biologic Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas



Key Vendors

- Amgen

- F. Hoffmann-La Roche

- Novo Nordisk

- Sanofi

Other Prominent Vendors

- Abbvie

- AstraZeneca

- Bavarian Nordic

- Baxter International

- Beijing Minhai Biotechnology

- Bharat Biotech

- Bharat Immunologicals and Biologicals

- bioCSL

- Biodel

- Bio Med

- Bristol-Myers Squibb

- Diamyd Medical

- DiaVacs

- Dynavax Technologies

- Eli Lilly

- Generex Biotechnology

- Hualan Biological Engineering

- Imunoloski Zavod

- Indian Immunologicals

- Janssen Pharmaceuticals

- JN International Medical

- Kaketsuken

- LG Life Sciences

- Macrogenics

- MannKind

- Merck & Co.

- Mitsubishi Tanabe Pharma

- Nuron Biotech

- Osiris Therapeutics

- Pfizer

- Protalix

- Protein Sciences

- Serum Institute of India

- Shenzhen Kangtai Biological Products

- Sinovac Biotech

- Tolerion

- Vacunas Finlay


- Zydus Cadila

Market Driver

- Aging Population

- For a full, detailed list, view our report

Market Challenge

- Requirement of Cold Storage

- For a full, detailed list, view our report

Market Trend

- Emergence of Targeted and Combination Therapies

- For a full, detailed list, view our report

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?

- What are the key market trends?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

- What are the market opportunities and threats faced by the key vendors?

- What are the strengths and weaknesses of the key vendors?

Complete report is available @

Roger Campbell
United States
Ph: 888-789-6604